Light Chain Bioscience (Switzerland)

Light Chain Bioscience (Switzerland)

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Light Chain Bioscience (Switzerland), Switzerland, covering academic research published from 2002 to 2023. Read More.


Open Access Percentage

63%


Total
Publications

274


Total Open
Publications

173


Total
Citations

12K


Open Access
Percentage

63%


Total
Publications

274


Total Open
Publications

173


Total
Citations

12K

Wikipedia

Website

download

Breakdown

20% 37% 6% 37%

Publisher Open

20%

Both

37%

Other Platform Open

6%

Closed

37%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022242628Total Publications
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

65

Hybrid 17%

26

No Guarantees 41%

65

Other Platform Open

Domain 87%

103

Institution 41%

48

Public 14%

17

Other Internet 7%

8

Preprint 3%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
106
Europe PMC
Domain
79
Figshare
Public
17
University of Zurich - Zurich Open Repository and Archive
Institution
15
Semantic Scholar
Public
15
University of Geneva - Archive ouverte UNIGE
Institution
11
ETH Zurich - Repository for Publications and Research Data
Institution
5
DOI
Other Internet
4
The University of Glasgow - Enlighten: Publications
Institution
3
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
3
1 / 7

Data updated 17 June 2024

Share

Share

Share